Cargando…
Microsatellite instability: a review of what the oncologist should know
The patients with high microsatellite instability (MSI-H)/mismatch repair deficient (dMMR) tumors recently have been reported that can benefit from immunotherapy, and MSI can be used as a genetic instability of a tumor detection index. However, many studies have shown that there are many heterogeneo...
Autores principales: | Li, Kai, Luo, Haiqing, Huang, Lianfang, Luo, Hui, Zhu, Xiao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6958913/ https://www.ncbi.nlm.nih.gov/pubmed/31956294 http://dx.doi.org/10.1186/s12935-019-1091-8 |
Ejemplares similares
-
Genetic Biomarkers in Melanoma of the Ocular Region: What the Medical Oncologist Should Know
por: Bol, Kalijn Fredrike, et al.
Publicado: (2020) -
The gut microbiome: what the oncologist ought to know
por: Lee, K. A., et al.
Publicado: (2021) -
Practical Considerations for the Use of Cannabis in Cancer Pain Management—What a Medical Oncologist Should Know
por: Gorzo, Alecsandra, et al.
Publicado: (2022) -
What do oncologists need to know about biosimilar products?
por: Leung, Linda K. S., et al.
Publicado: (2016) -
The filling defect of pulmonary artery, an imaging finding what we should know
por: Liu, Min, et al.
Publicado: (2020)